Apicidin-derived cyclic tetrapeptides

Details Apicidin-derived cyclic tetrapeptides Apicidin-derived cyclic tetrapeptides

A - Human Necessities

61

K

A61K 31/395 (2006.01) A61K 38/12 (2006.01) C07D 257/10 (2006.01) C07K 5/12 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2378849

Cyclic tetrapeptide compounds derived from apicidin therapeutically inhibit histone deacetylase activity and are represented by Formula (I).

Ces composés tétrapeptidiques cycliques dérivés d'apicidine, qui inhibent de façon thérapeutique l'activité d'histone déacétylase, correspondent à la formule (I).

Affiliated with

Also associated with

Rating

Apicidin-derived cyclic tetrapeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Apicidin-derived cyclic tetrapeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apicidin-derived cyclic tetrapeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1719057